Avidity biosciences to participate in upcoming investor conference

San diego , sept. 25, 2024 /prnewswire/ -- avidity biosciences, inc. (nasdaq: rna), a biopharmaceutical company committed to delivering a new class of rna therapeutics called antibody oligonucleotide conjugates (aocs™), today announced that avidity management will be participating in the following upcoming conference: chardan 8th annual genetic medicines conference on october 1 at 7:30 a.m.
RNA Ratings Summary
RNA Quant Ranking